Avidity Financial Statements From 2010 to 2026

Stocks USA . 
Stock . Avidity Biosciences
RNA Stock  USD 72.90  0.18  0.25%   
Avidity Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Avidity Biosciences' valuation are provided below:
Gross Profit
-467.3 M
Market Capitalization
11.2 B
Enterprise Value Revenue
452.3804
Revenue
20.9 M
Earnings Share
(4.18)
We have found one hundred twenty available fundamental signals for Avidity Biosciences, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Avidity Biosciences prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road.

Avidity Biosciences Total Revenue

9.15 Million

Check Avidity Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avidity Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 6.9 M, Total Revenue of 9.2 M or Research Development of 366.6 M, as well as many indicators such as Price To Sales Ratio of 424, Dividend Yield of 1.0E-4 or PTB Ratio of 2.15. Avidity financial statements analysis is a perfect complement when working with Avidity Biosciences Valuation or Volatility modules.
  
Build AI portfolio with Avidity Stock
Check out the analysis of Avidity Biosciences Correlation against competitors.
For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.

Avidity Biosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.9 B1.8 B450 M
Slightly volatile
Other Current Liabilities78.2 M74.4 M22.4 M
Slightly volatile
Total Current Liabilities118.4 M112.7 M35.2 M
Slightly volatile
Other Liabilities1.1 M1.1 M5.6 M
Slightly volatile
Accounts Payable5 M9.7 M4.1 M
Slightly volatile
Cash185.1 M252.8 M126.9 M
Slightly volatile
Other Assets0.860.9323 K
Slightly volatile
Long Term Debt1.5 M1.6 M4.5 M
Slightly volatile
Other Current Assets15.2 M14.5 M4.2 M
Slightly volatile
Total Liabilities167.8 M159.8 M73.8 M
Slightly volatile
Intangible Assets896.8 K939.6 K1.1 M
Slightly volatile
Common Stock10.3 K10.8 K210.1 K
Slightly volatile
Property Plant Equipment18.1 M17.3 M6.8 M
Slightly volatile
Short and Long Term Debt Total8.7 M7.8 M9.1 M
Slightly volatile
Property Plant And Equipment Net10.7 M21 M6.2 M
Slightly volatile
Non Current Assets Total26.1 M24.8 M7.8 M
Slightly volatile
Non Currrent Assets Other4 M3.8 M874.8 K
Slightly volatile
Cash And Short Term Investments1.8 B1.7 B417.8 M
Slightly volatile
Common Stock Total Equity3.4 K3.6 K227.4 K
Slightly volatile
Common Stock Shares Outstanding134.7 M128.3 M46.3 M
Slightly volatile
Long Term Debt Total1.5 M1.6 M4.8 M
Slightly volatile
Liabilities And Stockholders Equity1.9 B1.8 B436 M
Slightly volatile
Non Current Liabilities Total36.5 M36.8 M42.1 M
Very volatile
Property Plant And Equipment Gross31.7 M30.2 M8.8 M
Slightly volatile
Short and Long Term Debt3 M3.2 M2.8 M
Slightly volatile
Total Current Assets1.9 B1.8 B428.2 M
Slightly volatile
Non Current Liabilities Other38.5 K40.5 K139.1 K
Slightly volatile
Short Term Debt4 M4.4 M3.3 M
Slightly volatile
Current Deferred Revenue12.2 M24.1 M8.1 M
Slightly volatile
Net Receivables34.1 M32.5 M6.9 M
Slightly volatile
Short Term Investments1.5 B1.5 B302.5 M
Slightly volatile

Avidity Biosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue9.2 M12.5 M6.9 M
Pretty Stable
Research Development366.6 M349.1 M96.5 M
Slightly volatile
Cost Of Revenue2.4 M2.5 M12.5 M
Slightly volatile
Depreciation And Amortization3.4 M3.2 M1 M
Slightly volatile
Selling General Administrative104.1 M99.2 M26.4 M
Slightly volatile
Other Operating Expenses470.7 M448.3 M119.9 M
Slightly volatile
Total Operating Expenses470.7 M448.3 M119.8 M
Slightly volatile
Reconciled Depreciation3.4 M3.2 M1 M
Slightly volatile
Selling And Marketing Expenses1.7 M1.9 M2.1 M
Slightly volatile

Avidity Biosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditures8.5 M8.1 M2.5 M
Slightly volatile
Change To Account Receivables557.6 K627.3 K684.7 K
Slightly volatile
Total Cash From Financing Activities1.4 B1.4 B301.8 M
Slightly volatile
End Period Cash Flow205.8 M256.1 M117.3 M
Slightly volatile
Sale Purchase Of Stock485.1 K510.6 K4.6 M
Very volatile
Stock Based Compensation62 M59.1 M15.3 M
Slightly volatile
Begin Period Cash Flow200.2 M213.2 M102.8 M
Slightly volatile
Depreciation3.4 M3.2 M1 M
Slightly volatile
Change To Netincome32 M30.5 M10.3 M
Slightly volatile
Change To Liabilities8.2 M15.2 M5.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio424342936
Slightly volatile
Dividend Yield1.0E-41.0E-41.0E-4
Slightly volatile
Days Sales Outstanding893851230
Slightly volatile
Stock Based Compensation To Revenue4.454.241.4357
Slightly volatile
Capex To Depreciation1.852.291.2553
Slightly volatile
EV To Sales396320931
Slightly volatile
Payables Turnover0.260.275.6229
Very volatile
Sales General And Administrative To Revenue7.487.125.7197
Pretty Stable
Research And Ddevelopement To Revenue26.3325.0719.9134
Very volatile
Capex To Revenue0.610.580.2596
Slightly volatile
Cash Per Share6.9612.114.776
Slightly volatile
Days Payables Outstanding1.4 K1.4 K463
Slightly volatile
Current Ratio9.3714.166.536
Slightly volatile
Receivables Turnover0.420.444.5477
Slightly volatile
Capex Per Share0.03710.0570.0257
Slightly volatile
Revenue Per Share0.120.08790.0811
Slightly volatile
Interest Debt Per Share0.06660.07010.3534
Slightly volatile
Debt To Assets0.00480.0051.3801
Slightly volatile
Operating Cycle893851230
Slightly volatile
Days Of Payables Outstanding1.4 K1.4 K463
Slightly volatile
Ebt Per Ebit1.130.981.0516
Slightly volatile
Quick Ratio9.3714.166.536
Slightly volatile
Net Income Per E B T0.850.961.0453
Slightly volatile
Cash Ratio2.452.583.7783
Slightly volatile
Days Of Sales Outstanding893851230
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.810.920.99
Slightly volatile
Fixed Asset Turnover0.650.690.9287
Pretty Stable
Debt Ratio0.00480.0051.3801
Slightly volatile
Price Sales Ratio424342936
Slightly volatile
Asset Turnover0.00760.0080.0573
Slightly volatile

Avidity Biosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap471.5 M530.5 M579 M
Slightly volatile
Enterprise Value477.3 M537 M586.1 M
Slightly volatile

Avidity Fundamental Market Drivers

Avidity Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Avidity Biosciences Financial Statements

Avidity Biosciences stakeholders use historical fundamental indicators, such as Avidity Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Avidity Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Avidity Biosciences' assets and liabilities are reflected in the revenues and expenses on Avidity Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Avidity Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue24.1 M12.2 M
Total Revenue12.5 M9.2 M
Cost Of Revenue2.5 M2.4 M
Stock Based Compensation To Revenue 4.24  4.45 
Sales General And Administrative To Revenue 7.12  7.48 
Research And Ddevelopement To Revenue 25.07  26.33 
Capex To Revenue 0.58  0.61 
Revenue Per Share 0.09  0.12 
Ebit Per Revenue(39.99)(41.99)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
When determining whether Avidity Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avidity Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avidity Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avidity Biosciences Stock:
How To Invest In Avidity
Details
Is Avidity Stock a good investment?
Details
What is Avidity Biosciences' Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Avidity Biosciences Correlation against competitors.
For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avidity Biosciences. Anticipated expansion of Avidity directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Avidity Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(4.18)
Revenue Per Share
0.159
Quarterly Revenue Growth
4.34
Return On Assets
(0.20)
Return On Equity
(0.32)
Understanding Avidity Biosciences requires distinguishing between market price and book value, where the latter reflects Avidity's accounting equity. The concept of intrinsic value - what Avidity Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Avidity Biosciences' price substantially above or below its fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Avidity Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Avidity Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Avidity Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY